Today: 29 June 2026
Browse Category

ASX:NAB 14 December 2025 - 15 January 2026

NAB share price jumps 1% after ASX close as rate and rotation bets collide

NAB share price jumps 1% after ASX close as rate and rotation bets collide

National Australia Bank shares rose 1.1% to A$42.36 on Thursday, rebounding after earlier losses among Australian banks. The S&P/ASX 200 closed up 0.5% at 8,861.70, its highest since November, as miners set a new record and financials gained. Investors await Australia’s December quarter CPI on Jan. 28 and the Reserve Bank’s policy meeting on Feb. 2–3. NAB’s first-quarter trading update is due Feb. 18.
15 January 2026
·····
NAB shares slip into the weekend as traders brace for rates, data and the next update

NAB shares slip into the weekend as traders brace for rates, data and the next update

NAB shares closed at A$41.02 on Friday, down 0.2%, leading declines among Australia’s major banks as the S&P/ASX 200 slipped 0.03%. Investors are watching U.S. jobs data and upcoming Australian labour and inflation figures for signals on interest rates. NAB’s first-quarter trading update is scheduled for Feb. 18. No new company filings or statements affected the stock this week.
11 January 2026
··
ASX 200 closes higher after inflation cools; banks drag while Lynas jumps 14%

ASX 200 closes higher after inflation cools; banks drag while Lynas jumps 14%

The S&P/ASX 200 rose 0.15% to 8,695.6 Wednesday as miners and rare-earth stocks offset losses in banks after inflation slowed to 3.4% in November. Lynas Rare Earths surged 14.5% following China’s new export controls, while Commonwealth Bank, Westpac, ANZ, and NAB dropped up to 2%. The Australian dollar slipped to 67.28 U.S. cents. Investors await further CPI data due Jan. 28.
7 January 2026
·······
ANZ share price slides as sticky core inflation keeps RBA rate path in focus

ANZ share price slides as sticky core inflation keeps RBA rate path in focus

ANZ Group Holdings fell 1.5% to A$35.43, closing at its session low and underperforming the S&P/ASX 200, which rose 0.28%. The move followed flat November inflation data, keeping rate hike bets in play. Australia’s other major banks also closed lower. Interest-rate futures now price about a one-in-three chance of a Reserve Bank hike in February.
7 January 2026
·····
Westpac shares slide 2.2% as bank sell-off deepens ahead of Australia CPI test

Westpac shares slide 2.2% as bank sell-off deepens ahead of Australia CPI test

Westpac shares fell 2.2% to A$38.19 on Tuesday, with about 4 million shares traded, as investors braced for an inflation report due Wednesday. The decline tracked losses across major Australian banks and followed a 0.5% drop in the S&P/ASX 200. Money markets priced a 33% chance of a February rate hike after recent inflation data. Westpac’s first-quarter results are set for February 13.
6 January 2026
·····
NAB slides nearly 3% as rate-hike chatter hits bank stocks ahead of Australia inflation print

NAB slides nearly 3% as rate-hike chatter hits bank stocks ahead of Australia inflation print

National Australia Bank shares fell 3.0% to A$41.28 on Tuesday, underperforming the market as traders braced for Wednesday’s CPI data. Australia’s benchmark index slipped 0.92%, with financials among the main drags. Investors recalibrated for the risk of the Reserve Bank of Australia keeping rates higher for longer. NAB’s next trading update is set for February 18.
6 January 2026
··
Australia Stock Market Today (24 December 2025): ASX 200 Slips on Christmas Eve as Banks Weigh, Miners Hold Up on Record Metals

Australia Stock Market Today (24 December 2025): ASX 200 Slips on Christmas Eve as Banks Weigh, Miners Hold Up on Record Metals

Australia’s S&P/ASX 200 slipped 0.4% in a shortened Christmas Eve session, closing at 8,763 as investors took profits and trading volumes dropped to about 40% of the monthly average. Financial stocks led declines, with the big four banks down up to 0.8%, while miners and gold stocks rose, buoyed by record copper prices.
25 December 2025
···
National Australia Bank (ASX: NAB) Stock on 24 December 2025: Price Action, Latest News, Dividends, and 2026 Analyst Forecasts

National Australia Bank (ASX: NAB) Stock on 24 December 2025: Price Action, Latest News, Dividends, and 2026 Analyst Forecasts

National Australia Bank closed at A$42.43 on December 24, 2025, down 0.21% in a shortened ASX session with 1.38 million shares traded. The stock tracked declines across major Australian banks as investors weighed high valuations and concerns over profit margins. NAB issued over 700,000 new performance rights to employees in December, according to recent filings.
24 December 2025
National Australia Bank (ASX: NAB) Share Price Today: What’s Moving NAB Stock on 22 December 2025 — and Where Analysts See It Heading

National Australia Bank (ASX: NAB) Share Price Today: What’s Moving NAB Stock on 22 December 2025 — and Where Analysts See It Heading

NAB shares traded near A$42.08 on December 22, 2025, down for the day while some peers outperformed in a shortened Christmas week. The stock’s 52-week range stood at A$31.13 to A$45.25. Market focus remains on shifting rate expectations, with some analysts now forecasting RBA hikes as early as February. Broader consensus on the RBA’s next move remains uncertain.
22 December 2025
··
Australia Stock Market Today: ASX 200 Rises as Miners, Energy and Record Gold Lift Shares (22 December 2025)

Australia Stock Market Today: ASX 200 Rises as Miners, Energy and Record Gold Lift Shares (22 December 2025)

Australia’s S&P/ASX 200 rose 0.9% to around 8,701 by early afternoon Monday, led by gains in miners and energy stocks as commodity prices climbed. Nick Scali jumped 10% after upgrading its first-half outlook. Uranium stocks rallied, while WiseTech Global fell about 3%. Investors awaited RBA minutes and monitored new federal gas export rules.
22 December 2025
········
National Australia Bank (ASX: NAB) Stock: Latest News, Dividend, FY2025 Results, and 2026 Outlook (21 Dec 2025)

National Australia Bank (ASX: NAB) Stock: Latest News, Dividend, FY2025 Results, and 2026 Outlook (21 Dec 2025)

NAB shares closed at A$42.14 on 19 December 2025, up 13.6% for the year. The Reserve Bank of Australia held rates at 3.60% this month, but NAB now forecasts two hikes in early 2026. Mortgage competition remains intense, with NAB shifting focus to proprietary channels to defend margins. Investors are watching for further moves on rates and bank strategy.
21 December 2025
··
National Australia Bank (ASX: NAB) Stock: Latest News, Analyst Forecasts, and 2026 Outlook (20 December 2025)

National Australia Bank (ASX: NAB) Stock: Latest News, Analyst Forecasts, and 2026 Outlook (20 December 2025)

NAB shares closed at A$42.14 on Friday, up 0.84%, with a 52-week range of A$31.13 to A$45.25. Morgans and Goldman Sachs both rated NAB “Sell” in recent broker updates, citing valuation risks and below-consensus earnings forecasts. NAB raised fixed home loan rates by up to 0.20 points from 16 December. The bank also announced a JPY 18 billion subordinated note issue due 2040.
20 December 2025
··
NAB Share Price Today: National Australia Bank Limited (ASX:NAB) Stock News, Forecasts and Outlook for 18 December 2025

NAB Share Price Today: National Australia Bank Limited (ASX:NAB) Stock News, Forecasts and Outlook for 18 December 2025

NAB shares traded near A$41.81 on Thursday, with a market cap of about A$127.69 billion. The bank raised fixed home loan rates this week, now offering 5.39% p.a. for certain two-year owner-occupier loans. NAB and Commonwealth Bank expect the Reserve Bank of Australia to raise rates in February and May 2026. Analysts remain split on the stock’s outlook.
18 December 2025
···
1 2 3 4

Stock Market Today

  • Neurocrine Biosciences (NBIX) Gains as Strong Earnings Forecasts Boost Stock
    June 29, 2026, 5:49 AM EDT. Neurocrine Biosciences (NBIX) has emerged as a robust biotech performer with strong earnings momentum driven by its flagship treatment INGREZZA, which treats movement disorders. Analysts have sharply raised earnings per share (EPS) estimates for NBIX across upcoming quarters and fiscal years, reflecting increased confidence in the stock. INGREZZA's sales reached $2.86 billion in 2025, up 22% year-over-year, with projected growth continuing in 2026. The company also benefits from growing physician adoption and expanding patient awareness. Rising earnings forecasts, driven by strong operational performance and a broad consensus among analysts, have elevated NBIX to a Zacks Rank #1 (Strong Buy). Investors see Neurocrine's expanding portfolio and pipeline as key to sustaining growth beyond INGREZZA's success.

Latest articles

ServiceNow (NYSE:NOW) stock: $9 billion Friday jump puts contract base back in focus

ServiceNow (NYSE:NOW) stock: $9 billion Friday jump puts contract base back in focus

29 June 2026
ServiceNow (NYSE:NOW) surged 9.85% to $98.34 Friday, adding $9.1 billion in equity value—about 72% of its $12.64 billion Q1 current remaining performance obligations—as software stocks outperformed amid rotation out of AI names; the move comes ahead of a potential near-term bookings catalyst tied to price increases and legacy tier retirements, with short interest at 5.82% of float.
Nvidia holds $47 billion-per-point sway as Nasdaq tries for bounce

Nvidia holds $47 billion-per-point sway as Nasdaq tries for bounce

29 June 2026
Nvidia’s $4.7 trillion market value means every 1% stock move shifts $47 billion, putting massive index risk in focus as AI capex spending faces fresh scrutiny from new BIS data and rising China chip competition, with premarket gains tested by funding and substitution risks.
Microsoft rebound ahead of Nasdaq open puts AI spending in spotlight

Microsoft rebound ahead of Nasdaq open puts AI spending in spotlight

29 June 2026
Microsoft surged 5.7% to $372.97 in premarket trading, adding $149 billion in market value, as investors weigh soaring AI-driven capex—Q3 spending was about twice free cash flow—against strong cloud growth and a $37 billion AI revenue run rate, while analysts warn higher costs could pressure margins.
Go toTop